Stock ABT ABBOTT LABORATORIES
Add to a list
To use this feature you must be a member
Log inSign up

News Abbott Laboratories Swiss Exchange

Equities

ABT

US0028241000

Market Closed - Swiss Exchange
Other stock markets
 11:31:05 2024-02-19 EST 		5-day change 1st Jan Change
93 CHF -.--% Intraday chart for Abbott Laboratories -.--% -.--%
05-15 Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit MT
05-09 Drugmaker Abbott India posts Q4 profit rise on higher sales RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit
MT
Understanding Product-By-Process Claims In Patent Law
AQ
Drugmaker Abbott India posts Q4 profit rise on higher sales
RE
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing
MT
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
AQ
Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee
MT
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
PR
Dexcom's profit beats estimates on strong glucose monitor demand
RE
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength
RE
Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126
MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating
MT
UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept
MT
Correction to Health Care Roundup Article
DJ
RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating
MT
Raymond James Adjusts Abbott Laboratories' Price Target to $124 From $127, Keeps Outperform Rating
MT
Health Care Down After Abbott Earnings -- Health Care Roundup
DJ
Sector Update: Health Care Stocks Retreating Late Afternoon
MT
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET
DJ
S&P 500, Nasdaq dip as interest rate concerns, earnings weigh
RE
Abbott Laboratories Raises Midpoint of 2024 Guidance After First-Quarter Beat
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABT Stock
  4. ABT Stock
  5. News Abbott Laboratories
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW